Serum Intercellular Adhesion Molecule-1 Levels Following Dental Follicle-Derived Mesenchymal Stem Cell and Microfracture Treatments in a Rabbit Osteochondral Defect Model

This study aimed to compare serum intercellular adhesion molecule-1 (ICAM-1) levels following human dental follicle-derived mesenchymal stem cell and microfracture treatments in a rabbit model of osteochondral cartilage damage. Female New Zealand rabbits aged 2–3 months and weighing approximately 2.5 kg were used in the study. The animals were divided into three groups: an untreated defect control group, a group treated with 5 × 10⁶ lyophilized human dental follicle-derived mesenchymal stem cells applied to the defect area (xenogeneic application), and a group in which five microfracture holes were created at the base of the defect. At 16 weeks postoperatively, serum ICAM-1 levels were measured in a total of 16 serum samples, including four animals in the defect control group, six animals in the mesenchymal stem cell group, and six animals in the microfracture group, using a sandwich ELISA assay. A significant difference was found among groups in serum ICAM-1 levels (P < 0.001). The highest serum ICAM-1 level was detected in the defect control group (262.28 ± 20.59 ng/L), while the lowest level was found in the mesenchymal stem cell group (142.29 ± 3.91 ng/L). In the microfracture group, the value was 210.15 ± 24.19 ng/L. These findings suggest that dental follicle-derived mesenchymal stem cell treatment was associated with lower terminal serum ICAM-1 levels than microfracture treatment or untreated defects. However, serum ICAM-1 is not cartilage-specific, and further studies are needed to clarify the biological significance of these findings.

Authors

Institutions

Publication Details

Journal
Black Sea Journal of Health Science
Published
2026-11-15
DOI
https://doi.org/10.19127/bshealthscience.2037220
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Serum Intercellular Adhesion Molecule-1 Levels Following Dental Follicle-Derived Mesenchymal Stem Cell and Microfracture Treatments in a Rabbit Osteochondral Defect Model

İhsan YAĞCI, Elif Vargün, Funda Dinç Elibol, Deniz Genç et al.
Black Sea Journal of Health Science
Osteoarthritis Treatment and Mechanisms
article

Serum Intercellular Adhesion Molecule-1 Levels Following Dental Follicle-Derived Mesenchymal Stem Cell and Microfracture Treatments in a Rabbit Osteochondral Defect Model

İhsan YAĞCI, Elif Vargün, Funda Dinç Elibol, Deniz Genç, Ali Batuhan Bayırlı, Umut Canbek, Leyla Tekin, Burak Ekrem Çitil, Çiğdem Elif Demirci Dönmez, Tolga Meriç Dümbek, Osman Bulut
article en

Abstract

This study aimed to compare serum intercellular adhesion molecule-1 (ICAM-1) levels following human dental follicle-derived mesenchymal stem cell and microfracture treatments in a rabbit model of osteochondral cartilage damage. Female New Zealand rabbits aged 2–3 months and weighing approximately 2.5 kg were used in the study. The animals were divided into three groups: an untreated defect control group, a group treated with 5 × 10⁶ lyophilized human dental follicle-derived mesenchymal stem cells applied to the defect area (xenogeneic application), and a group in which five microfracture holes were created at the base of the defect. At 16 weeks postoperatively, serum ICAM-1 levels were measured in a total of 16 serum samples, including four animals in the defect control group, six animals in the mesenchymal stem cell group, and six animals in the microfracture group, using a sandwich ELISA assay. A significant difference was found among groups in serum ICAM-1 levels (P < 0.001). The highest serum ICAM-1 level was detected in the defect control group (262.28 ± 20.59 ng/L), while the lowest level was found in the mesenchymal stem cell group (142.29 ± 3.91 ng/L). In the microfracture group, the value was 210.15 ± 24.19 ng/L. These findings suggest that dental follicle-derived mesenchymal stem cell treatment was associated with lower terminal serum ICAM-1 levels than microfracture treatment or untreated defects. However, serum ICAM-1 is not cartilage-specific, and further studies are needed to clarify the biological significance of these findings.

Black Sea Journal of Health ScienceVol. 9(6)
Muğla University (TR)
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon